D-Wave, Quantum

D-Wave Quantum: A 99.9% Physics Milestone Meets a Wall Street Split

Published on 08/10/2026 at 18:32 | Redaktion boerse-global.de

D-Wave's peer-reviewed Nature paper signals gate-model progress, but Q2 revenue miss and insider sales temper optimism despite surging bookings.

D-Wave Quantum: Nature Paper Boosts Gate-Model Credibility Amid Q2 Revenue Miss
D-Wave Quantum Illustration mit AI erstellt übermittelt durch boerse-global.de

The most consequential news out of D-Wave Quantum this month wasn't the earnings miss that dominated trading headlines — it was a peer-reviewed paper in Nature describing a fast, high-precision two-qubit entanglement gate for the company's superconducting dual-rail architecture. The publication marks a significant step toward gate-model quantum computing, a domain long ceded to rivals while D-Wave focused on its annealing niche. For investors who had written the company off as a one-trick pony, the research suggests a broader technology roadmap than the market has historically credited.

That scientific validation arrived just as the company's commercial story grew more complicated. On Thursday, D-Wave reported second-quarter 2026 revenue of $3.07 million, falling short of the $4.03 million consensus, while its GAAP loss per share of $0.13 came in wider than the $0.09 analysts had penciled in. The net loss nevertheless narrowed sharply, from $167.3 million to $48 million, largely because non-cash warrant-related charges diminished. The adjusted EBITDA loss, however, widened to $37.1 million.

The Bookings Story Is Hard to Ignore

The top-line stagnation tells only part of the tale. First-half 2026 bookings surged 1,120 percent to $35.5 million, while remaining performance obligations climbed 668 percent to $40.7 million. A $20 million order from Florida Atlantic University for an Advantage2 system anchored the pipeline. Commercial customers now account for 62.4 percent of revenue, up from 45.1 percent, and recurring subscription revenue from the QCaaS cloud service rose 50 percent to $1.9 million. Second-quarter commercial revenue reached $1.9 million, up 37.6 percent from $1.4 million a year earlier.

That divergence between current revenue and future commitments has split the analyst community. Roth Capital cut its price target to $30 from $40 on Friday, and Canaccord Genuity followed with a reduction to $35 from $41, both citing persistent revenue weakness. Yet Craig-Hallum, Cantor Fitzgerald, and Evercore ISI reaffirmed buy ratings, Rosenblatt Securities initiated coverage with a Buy, and Northland Securities opened with Hold. Media reports of a potential 68 percent increase in U.S. federal quantum computing research funding have also lent sector-wide support.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Insider Sales and a Nasdaq Move

Adding a layer of caution: insiders sold roughly $1.74 million worth of shares over the past 90 days, including CEO Alan Baratz, CFO John Markovich, and HR chief Sophie Ames, all under pre-arranged trading plans.

The company also completed its voluntary listing switch from the NYSE to the Nasdaq at the end of July, with shares trading under the unchanged ticker QBTS since July 27. Baratz rang the opening bell to mark the debut — a technical change, but one that could improve visibility with certain index providers.

Management has also lined up appearances at the Needham semiconductor conference on August 20 and the Deutsche Bank Technology Conference on August 27, opportunities to sharpen the commercialization pitch for institutional investors.

The Forward Outlook

CFO John Markovich guided cautiously for the third quarter, expecting revenue "moderately" above Q2's $3.1 million, with the bulk of annual revenue weighted toward Q4 when two additional annealing systems ship. The company retains $546.2 million in cash and securities following its acquisition of Quantum Circuits.

The stock, meanwhile, has had a rough year. Shares trade around €17.70, down roughly 21.9 percent year-to-date, with annualized 30-day volatility of 106 percent — hardly a holding for the faint-hearted. The price sits about 5.7 percent below its 50-day moving average of €18.80, suggesting the recovery from March's lows has stalled. The stock has nonetheless gained 4.9 percent since the earnings release, as investors weigh the pipeline against the present revenue line, and it rose 13 percent in the fortnight after reports that AT&T expanded its use of D-Wave systems for network optimization, cutting a specific task from about an hour to roughly 15 seconds.

The tension is plain: a company delivering genuine scientific breakthroughs and a swelling order book, yet still asking investors to buy a promise rather than proof. The commercialization thesis remains unproven — and the volatility that comes with that uncertainty is part of the trade.

Ad

D-Wave Quantum Stock: New Analysis - 10 August

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

Disclaimer...

en | US26740W1099 | D-WAVE | boerse | 69934102 |